Notice

Notice to shareholders 2022-09-15

■ Our response to our shareholders’ inquiries about U.S. President Biden’s “Executive Order to launch a National Biotechnology and Biomanufacturing Initiative” are as follows: ■ After a thorough review of the Executive Order, we view it would have little, if any, impact on Celltrion Group. ■ Cell...

게시물 검색

제목	작성자
2022-03-11	Notice to Shareholders: Regarding the conclusion of the audi…	CelltrionHealthcare
2021-05-27	EULAR Virtual 2021 Celltrion Healthcare Industry Symposium	CelltrionHealthcare
2020-09-16	UEG Week Virtual 2020 Celltrion Healthcare Industry Symposiu…	CelltrionHealthcare
2020-04-13	Celltrion Group’s Statement on the development of a therapeu…	CelltrionHealthcare
2018-12-11	[Notice to shareholders] Celltrion Healthcare’s Statement on…	CelltrionHealthcare
2018-11-19	Biosimilars have the potential to deliver dramatic cost savi…	CelltrionHealthcare
2018-05-21	Biosimilars could facilitate early access to life changing b…	CelltrionHealthcare
2018-02-15	Celltrion’s Herzuma® (biosimilar trastuzumab) approved in Eu…	CelltrionHealthcare
2016-12-27	Celltrion Healthcare website renewed	CelltrionHealthcare

CelltrionHealthcare